Peter Lundh von Leithner
Overview
Explore the profile of Peter Lundh von Leithner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regula J, Lundh von Leithner P, Foxton R, Barathi V, Chui Ming G, Tun S, et al.
EMBO Mol Med
. 2019 May;
11(5).
PMID: 31040127
No abstract available.
2.
Lee V, Hosking B, Holeniewska J, Kubala E, Lundh von Leithner P, Gardner P, et al.
Diabetologia
. 2018 Aug;
61(11):2422-2432.
PMID: 30094465
Aims/hypothesis: Diabetic retinopathy is increasing in prevalence worldwide and is fast becoming a global epidemic and a leading cause of visual loss. Current therapies are limited, and the development of...
3.
Regula J, Lundh von Leithner P, Foxton R, Barathi V, Cheung C, Tun S, et al.
EMBO Mol Med
. 2017 May;
9(7):985.
PMID: 28533211
No abstract available.
4.
Regula J, Lundh von Leithner P, Foxton R, Barathi V, Cheung C, Tun S, et al.
EMBO Mol Med
. 2016 Oct;
8(11):1265-1288.
PMID: 27742718
Anti-angiogenic therapies using biological molecules that neutralize vascular endothelial growth factor-A (VEGF-A) have revolutionized treatment of retinal vascular diseases including age-related macular degeneration (AMD). This study reports preclinical assessment of...
5.
Catchpole I, Germaschewski V, Hoh Kam J, Lundh von Leithner P, Ford S, Gough G, et al.
PLoS One
. 2013 Jun;
8(6):e65518.
PMID: 23799019
Age-related macular degeneration (AMD) is a leading cause of legal blindness in the Western world. There are effective treatments for the vascular complications of neo-vascular AMD, but no effective therapies...
6.
Robbie S, Lundh von Leithner P, Ju M, Lange C, King A, Adamson P, et al.
Invest Ophthalmol Vis Sci
. 2013 Feb;
54(2):1490-500.
PMID: 23385800
Purpose: Two noninvasive delivery strategies for VEGF/PDGF receptor tyrosine kinase inhibitors (RTKI) were explored that exploited uveal retention as a means for establishing an ocular drug depot: a single oral...
7.
Lundh von Leithner P, Ciurtin C, Jeffery G
Mol Vis
. 2010 Apr;
16:570-81.
PMID: 20360994
Purpose: The vertebrate retina develops from the center to the periphery. In amphibians and fish the retinal margin continues to proliferate throughout life, resulting in retinal expansion. This does not...
8.
Lundh von Leithner P, Hoh Kam J, Bainbridge J, Catchpole I, Gough G, Coffey P, et al.
Am J Pathol
. 2009 Jun;
175(1):412-21.
PMID: 19541934
Vascular pathologies are known to be associated with age-related macular degeneration. Recently, age-related macular degeneration was associated with a single-nucleotide substitution of the complement factor H (CFH) gene, part of...
9.
Maass A, Lundh von Leithner P, Luong V, Guo L, Salt T, Fitzke F, et al.
Curr Eye Res
. 2007 Oct;
32(10):851-61.
PMID: 17963105
Purpose: We have recently described a novel way of imaging apoptosing retinal ganglion cells in vivo in the rat. This study investigated if this technique could be used in the...